Diwa, Khalif M.
HRN: 27-84-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/01/2026
01/08/2026
IV
90 Mg
Q24hrs
Pcap C
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes